Belite Bio (BLTE) Tax Rate (2023 - 2024)

Belite Bio's (BLTE) quarterly Tax Rate came in at 0.07% in Q3 2024, up 8.0% year-on-year from 0.06% in Q4 2023, and up 190.53% quarter-over-quarter from 0.08% in Q1 2024.

Belite Bio (BLTE) Tax Rate (2023 - 2024) Analysis & Trends

Belite Bio's Tax Rate history runs 2 years deep, the most recent figure standing at 0.07% for Q3 2024.

  • On a quarterly basis, Tax Rate rose 8.0% year-over-year to 0.07% in Q3 2024; TTM through Dec 2024 was 0.0%, a 7.0% increase from a year earlier, with the FY2025 full-year figure at 0.18%, up 19.0% from the prior year.
  • Tax Rate climbed to 0.07% in Q3 2024 per BLTE's latest filing, from 0.08% in the prior quarter.
  • Across five years, Tax Rate topped out at 0.07% in Q3 2024 and bottomed at 0.09% in Q1 2023.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -0.34
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 5.61
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 12.29
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 17.68
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 12.51
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -13.70
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 7.07

Historic Data

Download Data
DateValue
Sep 30, 2024 0.07
Sep 30, 2024 0.07
Sep 30, 2024 0.07
Mar 31, 2024 -0.08
Mar 31, 2024 -0.08
Mar 31, 2024 -0.08
Dec 31, 2023 0.01
Dec 31, 2023 0.01
Dec 31, 2023 0.01
Sep 30, 2023 -0.01
Sep 30, 2023 -0.01
Sep 30, 2023 -0.01
Jun 30, 2023 -0.04
Jun 30, 2023 -0.04
Jun 30, 2023 -0.04
Mar 31, 2023 -0.09
Mar 31, 2023 -0.09
Mar 31, 2023 -0.09